CVE-2008-7173

Description

The Jura Internet Connection Kit for the Jura Impressa F90 coffee maker does not properly restrict access to privileged functions, which allows remote attackers to cause a denial of service (physical damage), modify coffee settings, and possibly execute code via a crafted request. NOTE: this issue is being included in CVE because the denial of service may include financial loss or water damage.

Category

10.0
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 12.59% Top 10%
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/archive/1/493440/100/0/threaded mailing list
http://osvdb.org/46407 vdb entry
http://www.securityfocus.com/bid/29767 vdb entry
http://www.securityfocus.com/archive/1/493433/100/0/threaded mailing list
http://news.cnet.com/8301-10784_3-9970757-7.html
http://www.securityfocus.com/archive/1/493387/100/0/threaded mailing list
http://attrition.org/pipermail/vim/2008-June/002002.html mailing list

Frequently Asked Questions

What is the severity of CVE-2008-7173?
CVE-2008-7173 has been scored as a critical severity vulnerability.
How to fix CVE-2008-7173?
To fix CVE-2008-7173, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-7173 being actively exploited in the wild?
It is possible that CVE-2008-7173 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~13% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.